Li B, Yan J, Pu J, Tang J, Xu S, Wang X. Esophageal dysfunction in systemic sclerosis: an update. Rheumatol Ther. 2021;8:1535–49.
Snyder DL, Crowell MD, Kahn A, Griffing WL, Umar S, Ramirez FC. Prevalence of Barrett’s esophagus in female patients with scleroderma. Am J Gastroenterol. 2021;116:517–21.
Kahan A, Bour B, Couturier D, Amor B, Menkes CJ. Nifedipine and esophageal dysfunction in progressive systemic sclerosis. A controlled manometric study. Arthritis Rheum. 1985;28:490–5.
Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76:1327–39.
Kadakuntla A, Juneja A, Sattler S, et al. Dysphagia, reflux and related sequelae due to altered physiology in scleroderma. World J Gastroenterol. 2021;27:5201–18.
Biswas Roy S, Banks P, Kunz M, et al. Prevalence and natural history of Barrett’s esophagus in lung transplant: a single-center experience. Ann Thorac Surg. 2019;107:1017–23.
Hughes J, Lockhart J, Joyce A. Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain? Br J Clin Pharmacol. 2007;64:83–9.
Jean F, Aubert A, Bloch F, et al. Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis. Arthritis Rheum. 1986;29:1054–5.
Kim HS, Conklin JL, Park H. The effect of sildenafil on segmental oesophageal motility and gastro-oesophageal reflux. Aliment Pharmacol Ther. 2006;24:1029–36.
Lee TH, Lee JS, Hong SJ, et al. Examination of the effects of vardenafil on esophageal function using multichannel intraluminal impedance and manometry. J Neurogastroenterol Motil. 2012;18:399–405.
Kikendall JW, Mellow MH. Effect of sublingual nitroglycerin and long-acting nitrate preparations on esophageal motility. Gastroenterology. 1980;79:703–6.
Tutuian R, Castell DO. Esophageal motility disorders (distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter): modern management. Curr Treat Options Gastroenterol. 2006;9:283–94.
Wei A, Gu Z, Li J, et al. Clinical adverse effects of endothelin receptor antagonists: insights from the meta-analysis of 4894 patients from 24 randomized double-blind placebo-controlled clinical trials. J Am Heart Assoc. 2016;5: e003896.
Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32:1367–72.
Kim JJ, Mulki RH, Sebastian KM. Recalcitrant esophageal stricture secondary to mycophenolate mofetil. Case Rep Gastrointest Med. 2020;2020:8817801.
PubMed PubMed Central Google Scholar
Nguyen T, Park JY, Scudiere JR, Montgomery E. Mycophenolic acid (CellCept and Myfortic) induced injury of the upper GI tract. Am J Surg Pathol. 2009;33:1355–63.
Matsuda R, Yamamichi N, Shimamoto T, et al. Gastroesophageal reflux disease-related disorders of systemic sclerosis based on the analysis of 66 patients. Digestion. 2018;98:201–8.
Seminerio J, McGrath K, Arnold CA, et al. Medication-associated lesions of the GI tract. Gastrointest Endosc. 2014;79:140–50.
Lazenby JP, Guzzo MR, Harding SM, et al. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma. Chest. 2002;121:625–34.
Bigard MA, Pelletier AL. Esophageal complications of non-steroidal antiinflammatory drugs. Gastroenterol Clin Biol. 2004;28(3):58–61.
Avidan B, Sonnenberg A, Schnell TG, Budiman-Mak E, Sontag SJ. Risk factors of oesophagitis in arthritic patients. Eur J Gastroenterol Hepatol. 2001;13:1095–9.
de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016–21.
Martín-Merino E, Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S. Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2010;31:1132–40.
Brahm NC, Kelly-Rehm MC. Antidepressant-mediated gastroesophageal reflux disease. Consult Pharm. 2011;26:274–8.
Rushnak MJ, Leevy CM. Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study. Am J Gastroenterol. 1980;73:127–30.
Jung HK, Choung RS, Talley NJ. Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol Motil. 2010;16:22–9.
留言 (0)